HI homepage

Thumbnail
Neuroimaging not necessary for all patients who present to ED with vertigo

The decision to utilize such scans is challenging for emergency providers, with the condition most often of benign origin, according to new research published in the journal of Emergency Radiology. 

 

 

Thumbnail
Rad tech loses credentials after he's caught drinking on the job

Reports indicate that the radiographer purchased and drank a bottle of wine during one of his lunch breaks. 

artificial intelligence money finance acquisition
HHS seeks input on how reimbursement, regulation could bolster use of healthcare AI

The key agency released a request for information on Dec. 19, asking for broad input on how it can accelerate the adoption of AI in clinical care. 

money court scale of justice ruling legal settlement
Rayus Radiology agrees to class action settlement in case over alleged website tracking

Patients first sued the St. Louis Park, Minnesota-based imaging group in two separate lawsuits, both filed in 2023, over its use of tracking pixels to allegedly filter info to Facebook and other third parties. 

Thumbnail
Short-selling investment startup accuses RadNet of exaggerating its success

Founded in 2023, Hunterbrook is an investigative news and investment outlet, which creates reports criticizing publicly traded companies and then benefits from the corresponding drop in share prices

Thumbnail
New iron-based imaging agent significantly improves brain tumor visualization

Ferumoxytol is used primarily in medications that treat anemia, but the FDA recently cleared it for deployment in brain imaging as well.

Around the web

RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model. 

 

Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.

A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.